Sone Capital Management’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.85M Sell
23,016
-20,479
-47% -$4.39M 0.37% 80
2026
Q1
$9.62M Sell
43,495
-987
-2% -$241K 0.81% 48
2025
Q4
$11.3M Buy
+44,482
New +$11.2M 0.92% 46
2025
Q3
Sell
-43,660
Closed -$10.5M 121
2025
Q2
$10.5M Buy
43,660
+16,855
+63% +$3.92M 0.97% 42
2025
Q1
$6.08M Sell
26,805
-6,104
-19% -$1.34M 0.63% 58
2024
Q4
$6.76M Buy
+32,909
New +$7.22M 0.86% 44

Other funds holding STE

Sone Capital Management's STE Position: Q2 2026 in Review

Sone Capital Management reduced its Steris (STE) stake by 47% in Q2 2026, selling an estimated $4.39M and leaving 23,016 shares worth $4.85M. The position accounts for 0.37% of the portfolio, ranked #80.

Sone Capital Management first reported a position in STE in Q4 2024 and has held it in 6 quarters since. The position peaked at $11.3M in Q4 2025. 833 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Sone Capital Management held 23,016 shares of Steris worth $4.85M as of Q2 2026.
  • Sone Capital Management sold 20,479 Steris shares in Q2 2026, an estimated $4.39M.
  • Steris made up 0.37% of Sone Capital Management's portfolio in Q2 2026, its #80 holding.
  • Sone Capital Management first reported a position in Steris in Q4 2024 and has held it in 6 quarters since.
  • Sone Capital Management's Steris position peaked at $11.3M in Q4 2025.
  • 833 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Sone Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.